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Abstract
Objective—To compare rates of complications associated with cesarean delivery in HIV-
infected and HIV-uninfected women in the United States and to investigate trends in such 
complications across four study cycles spanning the implementation of HAART in the United 
States (1995–1996, 2000–2001, 2005–2006, 2010–2011).
Design—The Nationwide Inpatient Sample from the Healthcare Cost and Utilization Project is 
the largest all-payer hospital inpatient care database in the United States; when weighted to 
account for the complex sampling design, nationally representative estimates are derived. After 
restricting the study sample to women aged 15–49 years, our study sample consisted of 
approximately 1 090 000 cesarean delivery hospitalizations annually.
Methods—Complications associated with cesarean deliveries were categorized as infection, 
hemorrhage, or surgical trauma, based on groups of specific International Classification of 
Diseases 9th revision codes. Length of hospitalization, hospital charges, and in-hospital deaths 
were also examined.
Results—The rate of complications significantly decreased during the study periods for HIV-
infected and HIV-uninfected women. However, rates of infectious complications and surgical 
trauma associated with cesarean deliveries remained higher among HIV-infected, compared with 
HIV-uninfected women in 2010–2011, as did prolonged hospital stay and in-hospital deaths. 
Length of hospitalization decreased over time for cesarean deliveries of HIV-infected women to a 
greater extent compared with HIV-uninfected women.
Conclusion—In the United States, rates of cesarean delivery complications decreased from 1995 
to 2011. However, rates of infection, surgical trauma, hospital deaths, and prolonged 
hospitalization are still higher among HIV-infected women. Clinicians should remain alert to this 
persistently increased risk of cesarean delivery complications among HIV-infected women.
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Introduction
Similar to overall trends in cesarean delivery rates in the United States, the proportion of 
HIV-infected women having a cesarean delivery has increased in recent years [1–3]. This is 
likely due, in part, to the role of cesarean delivery in reducing the risk of mother-to-child 
transmission (MTCT) of HIV type 1. Research conducted in the 1990s demonstrated that 
cesarean delivery performed prior to the onset of labor and prior to the rupture of the 
amniotic membranes can substantially reduce the risk of MTCT of HIV [4,5]. As such, the 
American College of Obstetricians and Gynecologists and the US Public Health Service 
recommend that HIV-infected women with plasma viral loads higher than 1000 copies/ml be 
counseled on the benefits of cesarean delivery performed at 38 weeks gestation to prevent 
MTCT of HIV [6,7]. Scheduled cesarean deliveries performed for HIV prevention are a 
subset of elective cesarean deliveries, which are generally performed at 39 weeks (before 
onset of labor) and may include those performed for medical or obstetrical indications as 
well as those performed upon maternal request [8].
Several studies have demonstrated that HIV-infected women are at increased risk of 
perioperative morbidity from cesarean delivery compared with HIV-uninfected controls [9–
16], and their risk for morbidity is higher with cesarean as compared with vaginal delivery 
[4,9,17–19]. Most of this increased risk for morbidity is related to infection (e.g., urinary 
tract infection, pneumonia, wound infection, septicemia), which is elevated for all women 
undergoing cesarean delivery [20], such that the risks are greatest for cesarean deliveries 
performed after onset of labor or ruptured membranes, intermediate with scheduled cesarean 
delivery, and lowest with vaginal delivery [21]. Although the studies upon which existing 
US guidelines were made demonstrate a clear benefit in reducing MTCT that outweighs 
potential risks of morbidity, most were conducted before the widespread use of HAART 
[21–23]. As maternal viral load is significantly associated with risk of MTCT [24–30], the 
additional benefit of scheduled cesarean delivery when full viral suppression has been 
achieved through the use of HAART has been questioned [31–33], and the US guidelines, as 
mentioned, do not recommend elective cesarean delivery in women with undetectable viral 
load [4,5].
Given that perioperative morbidity associated with cesarean delivery is correlated with the 
degree of immunosuppression [9–13,17,30], the risks for morbidity may be lower for HIV-
infected women on HAART. Furthermore, as any elevation in morbidity associated with 
cesarean deliveries needs to be balanced against benefits of preventing MTCT in the era of 
HAART, research is needed to assess the extent to which cesarean delivery continues to be 
associated with increased risk of complications. This study addresses the question of 
whether morbidity rates associated with cesarean delivery have declined for HIV-infected 
women with the widespread use of HAART in the United States. More specifically, we 
conducted a large US population-based analysis of hospitalization data, using the 
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Nationwide Inpatient Sample (NIS) database to test two hypotheses: (i) that the rate of 
complications associated with cesarean deliveries among HIV-infected women has declined 
from 1995–1996 (pre-HAART) to 2000–2001 (early combination- HAART), 2005–2006, 
and 2010–2011 (both times of widespread use of combination HAART); and (ii) that 
complications associated with cesarean delivery in HIV-infected women have declined to a 
greater degree, compared with HIV-uninfected women, from 1995–1996 to 2010–2011.We 
also evaluated changes in rates of cesarean deliveries and elective cesarean deliveries among 
HIV-infected, compared with HIV-uninfected women in the United States over time.
Methods
Data source and definition of exposures and outcomes
The NIS of the Agency for Healthcare Research and Quality is the largest all-payer hospital 
inpatient care database in the United States providing a wide range of information on 
hospitalizations. It is a stratified probability sample of approximately 20% of all US 
community hospitals on the basis of five characteristics: geographic region, ownership, 
rural/urban location, teaching status, and bed size. Before 2005, the American Hospital 
Association (AHA) defined community hospitals as nonfederal, short-term (average stay 
<30 days) general, and specialty hospitals open to the public. In 2005, the AHA added long-
term acute care facilities (stays >25 days) to the definition of community hospitals [34].
The NIS includes all discharges from selected hospitals and provides information on 5 to 8 
million hospital stays from an average of 1000 hospitals each year. Each record is weighted 
to account for the complex sampling design and when weighted, nationwide estimates can 
be derived [34]. To track changes in cesarean delivery-associated complications in 
conjunction with increasing use of HAART, this analysis includes data from 1995 to 1996, 
2000 to 2001, 2005 to 2006, and 2010 to 2011. For these years, we identified all pregnancy 
hospitalizations that resulted in a delivery by using International Classification of Diseases, 
9th revision, Clinical Modification (ICD-9-CM) codes 650, and V27, procedure codes of 
720–721, 722.1, 722.9, 723.1, 723.9, 724, 725.1–725.4, 726, 727.1, 727.9, 728–729, 
732.2735.9, 736, 740–742, 744, and 749.9, and diagnosis-related group codes of 370–375. 
The ICD-9 algorithm developed by Gregory et al. [35] was used to identify cesarean 
deliveries and determine if they were elective. An elective cesarean delivery was defined as 
a procedure that occurred prior to the onset of labor (defined by ICD-9-CM codes 652.1, 
653, 656.3, 659.0, 659.1, 660–662, 663.0) without regard to previous history of cesarean 
delivery; repeat cesarean deliveries were categorized as elective per the modified algorithm 
by Meikle et al. [8].
Our primary outcomes included occurrence of at least one cesarean delivery-associated 
complication, occurrence of specific cesarean delivery-associated complications, extended 
hospital stay (>7 days), hospital charges, and deaths during hospitalization. All in-hospital 
deaths were included regardless of length of stay. We defined the specific cesarean delivery-
associated complications as follows:
1. Infection, including pneumonia (ICD-9-CM codes 486, 507.0–507.8, 514); urinary 
tract infection, including acute pyelonephritis (599.0, 590.9, 646.64 760.1, 590.1); 
Kourtis et al. Page 3













and other infections, including genital tract and pelvic infection (639.0), 
postoperative infection and other complications of obstetrical surgical wounds 
(998.59, 998.5, 674.34, 674.14), wound dehiscence (998.31), sepsis, septicemia, 
and other infection (670.24, 995.91, 995.92, 038, 999.3), major puerperal infection 
(670.04, 670.84), puerperal endometritis (670.14), unspecified inflammatory 
disease of the uterus (615.9), thrombophlebitis (670.34), and fever (780.60, 
672.04).
2. Hemorrhage, including postpartum hemorrhage (666.14, 666.24, 661.24, 666.34), 
blood transfusion (V58.2), and acute posthemorrhagic anemia (285.1).
3. Thrombosis, including deep thrombophlebitis (671.44), obstetrical pulmonary 
embolism and deep vein thrombosis (673.04, 673.24), obstetrical pyemic and septic 
embolism (67673.34), other pulmonary embolism (673.84).
4. Surgical trauma, including obstetrical injury to pelvic organs (665.54), small bowel 
obstruction or ileus (560.9, 560.1), obstetrical pelvic hematoma (665.74), 
unspecified obstetrical trauma (665.94), and non-healing surgical wound (998.83).
‘Any complication’ included any of the four complications above.
Statistical analysis
Our primary independent variables were HIV status and year of hospitalization; subanalyses 
were conducted to assess differences by HIV status among all cesarean deliveries and 
elective cesarean deliveries as defined above. To identify women infected with HIV, we 
used ICD-9-CM codes: 042, 079.53, 279.10, 279.19, 795.71, 795.8, and V08 [36]. Patient 
age, primary expected payer (indicator of socioeconomic status), hospital teaching status/
location, alcohol/substance abuse (ICD-9 codes 291–292, 303, 305, 648.3, 655.5, 965.0, 
V65.42), anemia (ICD-9 codes 648.2, 280–285), and diabetes (preexisting and gestational) 
(ICD-9 codes 250, 648.0, 648.8, 790.29, 791.5) were included as possible confounders, 
because they have been previously associated with complications related to cesarean 
delivery among HIV-infected women [19,30]. Race was not examined because it is often not 
reported by states or there are inconsistencies and missing values. For 1995 and 2010 (pre-
HAART and recent HAART eras, respectively) we compared the distribution of these 
characteristics among HIV-infected and HIV-uninfected women for all cesarean deliveries 
and for elective cesarean deliveries. Differences were evaluated with chi-square tests (alpha 
= 0.05).
For 1995–1996 and 2010–2011, we compared the rate of each complication per 1000 
deliveries among HIV-infected and HIV-uninfected women for cesarean deliveries overall, 
and separately for elective cesarean deliveries. Differences in complication rates for HIV-
infected and HIV-uninfected women were assessed with the Student’s t-test (alpha = 0.05). 
As there were very few thrombotic events, resulting in unstable estimates, these results are 
not presented. Multivariable logistic regression models were used to assess the odds of each 
complication for HIV-infected vs. HIV-uninfected women, adjusting for patient age, 
primary expected payer, hospital teaching status/location, anemia, diabetes, and alcohol/
substance abuse [19,30].
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To further assess trends in complications over time, we compared data across four study 
periods: 1995–1996 (reference period), 2000–2001, 2005–2006, and 2010–2011, in 
multivariable logistic regression models, stratified by HIV status. We used 2-year periods to 
derive stable estimates, given the small number of outcomes in some categories per year, 
adjusting for the same potential confounders. Additionally, we evaluated differences in 
trends among HIV-infected and HIV-uninfected women over time by including an 
interaction term of study period and HIV status in a multivariable logistic regression model, 
and testing the significance of the interaction term. To assess trends in mean hospital 
charges for cesarean deliveries by HIV status, multiple linear regression was performed 
adjusting for the same potential confounders Hospital charges were adjusted for inflation 
using the Bureau of Labor Statistics’ Consumer Price Index.
A sensitivity analysis was performed to examine the effect of changes in the distribution of 
primary vs. repeat elective cesarean delivery over the study period. A repeat cesarean 
delivery was defined using ICD-9-CM code 654.2
Results
There were a total of 2798 estimated cesarean deliveries among HIV-infected women and 1 
270 952 among HIV-uninfected women in the United States in 2010; this represents 58.5% 
of all deliveries among HIV-infected women for that year, compared with 33% for HIV-
uninfected women (P < 0.0001). The number of cesarean deliveries among HIV-infected 
women in the United States steadily increased from 934 in 1995 to 2290 in 2000 to 2354 in 
2005; representing 19.6, 49.9, and 57.5% of all deliveries among HIV-infected women, 
respectively. In contrast, among HIV-uninfected women, the respective proportions of 
deliveries that were cesarean deliveries were 21, 22.8, and 31.1%. Since 2000, the great 
majority of cesarean deliveries among HIV-infected women were elective (44.6% in 1995, 
88.9% in 2000, 91.5% in 2005, and 90.9% in 2010). The corresponding proportions for 
elective cesarean delivery among HIV-uninfected women were 46.1% in 1995, 62% in 
2000, 70.3% in 2005, and 73.1% in 2010.
HIV-infected women had a higher prevalence of anemia and alcohol/substance abuse 
compared with HIV-uninfected women for all years studied. HIV-infected women were 
more likely to have public payer insurance, delivery at an urban teaching hospital and be 
located in the South compared with HIV-uninfected women undergoing a cesarean delivery, 
for all years studied (1995 and 2010 data shown in Table 1). Cesarean delivery 
hospitalizations of HIV-infected women were, on average, slightly longer for all years 
studied and were associated with higher mean hospital charges in 1995 (P < 0.001), 2000 (P 
= 0.003), and 2010 (P < 0.001) (Table 1).
The rate of any complications associated with cesarean delivery in 2010–2011 was 
116.6/1000 deliveries among HIV-infected women in the Unites States, compared with 
67.9/1000 deliveries among HIV-uninfected women. In 1995–1996, the corresponding rates 
for HIV-infected and HIV-uninfected women were 210.6/1000 deliveries and 118.9/1000 
deliveries, respectively (Table 2). Compared with HIV-uninfected women, cesarean 
deliveries of HIV-infected women in 2010–2011 had greater odds of being associated with 
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infectious complications (adjusted odds ratios [aOR], 1.66; 95% confidence interval [CI]: 
1.18–2.35), surgical trauma (aOR, 2.45; 95% CI, 1.41–4.26) and extended hospitalizations 
(aOR, 2.09, 95% CI: 1.58–2.74). Even though a rare outcome, cesarean deliveries of HIV-
infected women had greater odds of resulting in death, compared with those of HIV-
uninfected women (aOR, 9.06, 95% CI, 2.60–31.58) (Table 2). With the exception of 
surgical trauma, similar relationships were observed in 1995–1996 (Table 2). As almost all 
cesarean deliveries among HIV-infected women in 2010–2011 were elective, the 
relationships mentioned above were also seen in the respective comparisons of elective 
cesarean delivery complication rates (Table 2).
For all women, the rate of infections among cesarean deliveries decreased from 1995 to 
2010 with a similar pattern among the HIV-infected and HIV-uninfected women (Fig. 1). 
The rate of surgical trauma among cesarean deliveries of HIV-uninfected women decreased 
over the study period, whereas the rate of surgical trauma among cesarean deliveries of 
HIV-infected women increased. Among HIV-uninfected women, the odds of any 
complication, each of the complication types, extended hospital stay and deaths associated 
with cesarean delivery significantly decreased over the study period, with most of the 
decrease occurring by 2005–2006, (Table 3). In contrast, among HIV-infected women, 
significant decreases were only observed for infection or any complication beginning in 
2005–2006, and for prolonged hospital stay during each of the periods of observation; again, 
little or no additional decrease occurred in the final year of observation (Table 3). The 
decreases for elective cesarean delivery complications mirrored those observed for all 
cesarean deliveries (Table 3). There was no statistically significant interaction of HIV status 
and study period for any complication, infection, hemorrhage, and death. There was a 
marginally significant interaction of HIV status and time for surgical trauma (P = .07), and a 
significant interaction for extended hospital stay (P = 0.02). The odds of an extended 
hospital stay decreased since 1995 to a greater extent for cesarean deliveries of HIV-infected 
women (Table 3). For all cesarean deliveries, adjusted mean charges (in 2010 $) for HIV-
infected women were $15 793 in 1995–1996 and were not significantly different in 2000–
2001 or 2005–2006 but were higher in 2010–2011, when adjusted mean charges were $24 
104 (P < 0.001). For HIV-uninfected women, mean charges increased significantly at each 
time period compared with the referent time period of 1995–1996 (Table 3). This pattern 
was identical in women with elective cesarean deliveries.
The sensitivity analysis of primary vs. repeat cesarean deliveries showed a slight increase in 
the proportion of repeat cesarean deliveries among all elective deliveries from 1995–2010 
among the HIV-uninfected women (from 57 to 60%), but a slight corresponding decrease 
among HIV-infected women (from 56 to 53%); there were some fluctuations for in-between 
years among the HIV-infected women (results not shown). Overall, complication rates were 
slightly higher for primary, compared with repeat, elective cesarean deliveries, but these 
differences were mostly not statistically significant among the HIV-infected women. The 
trends in complications over time per type of elective cesarean delivery mirrored those 
observed for elective cesarean deliveries overall (results not shown).
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In this analysis of multiple years of nationally representative US hospitalization data, we 
find that the rates and adjusted odds of infectious complications, surgical trauma, prolonged 
hospitalization and in-hospital deaths remain higher among HIV-infected, compared with 
HIV-uninfected, women undergoing a cesarean delivery, even in the era of widespread use 
of HAART during pregnancy. With the exception of surgical trauma, rates of these 
complications have decreased in both HIV-infected and HIV-uninfected women over the 15-
year study period encompassing the implementation of HAART, and appear to have 
plateaued over the past several years. However, the rate of extended hospital stay decreased 
to a greater extent for cesarean deliveries of HIV-infected women.
Most studies examining whether morbidity associated with elective cesarean delivery has 
declined in parallel with changes in the management of HIV during pregnancy were 
conducted during the integration of antiretroviral monotherapy into practice and ended just 
as combination therapies were being introduced [9,17,19]. Only a few more recent studies 
have focused on women receiving HAART. In two small studies comparing HIV-infected 
women to HIV-uninfected controls, the difference in major complications between the two 
groups (severe anemia, need for postpartum surgical procedures, pneumonia, peritonitis, 
sepsis, thrombosis, diffuse intravascular coagulation and subileus/ileus) was not significant 
[30,37], although one of the studies did find differences in minor complications (mild 
anemia, urinary tract infections, fever), the length of hospital stays, and blood loss [37]. 
Given that major complications are rare, these smaller studies were insufficiently powered to 
evaluate the comparative frequencies for the more severe outcomes. In a third population-
based recent study of HIV-infected women in France, complication rates were lower 
following vaginal, compared with cesarean delivery; complications were mainly infections 
or hemorrhage [38]. Whereas the unadjusted rate of hemorrhage was higher among HIV-
infected women in this study, when adjusting for sociodemographic factors and underlying 
morbidity the risk became lower, compared with HIV-uninfected women.
A recent meta-analysis pooling data from four studies conducted in Europe and the United 
States (1995–2007) demonstrated that among women who had a cesarean delivery HIV 
infection was associated with six times the risk of puerperal sepsis compared with HIV-
uninfected women [39]. Among 10 studies containing information on wound infection 
conducted in Africa, Europe and the United Studies from 1995 to 2010, the pooled odds 
ratio [OR] for this outcome, comparing HIV-infected to HIV-uninfected women, was 1.75 
(CI: 1.20–2.55) [39]. Twelve studies examining endometritis (conducted in Africa, Europe, 
the United States, and Thailand, 1995–2010) showed that HIV-infected women had over 
double the odds of endometritis than HIV-uninfected women. One study that examined the 
association between HIV and postpartum hemorrhage among women having a cesarean 
delivery found no association [40].
The current study has the largest number of observations from any single study, and the 
results reflect data that are nationally representative for the United States. Our findings 
confirm a persistently elevated risk of complications, mostly infection, associated with 
cesarean delivery among HIV-infected women, even in the combination antiretroviral era. 
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Although a study suggested that the higher complication risk was only for women with 
CD4+ cell count below 500 cells/µl [30], a higher rate of complications was seen even in 
women without immune deficiency in a French study [8]; we could not examine this factor, 
as information on CD4+ cell counts is not available in NIS.
We observed an increase in the proportion of cesarean deliveries among all deliveries of 
HIV-infected women in the United States over the period of observation; the proportion for 
2010, 58%, was almost double the corresponding proportion for HIV-uninfected women. 
The great majority of these cesarean deliveries (over 90%) were elective, likely because of 
clinical guidelines recommending a prelabor cesarean delivery for HIV-infected women, 
unless their HIV viral load is less than 1000 copies/ml at 34 weeks gestation. Although it is 
possible that some women with viral load less than this cutoff may still undergo cesarean 
delivery, as most HIV-infected women in the United States are now on HAART regimens 
during pregnancy and achieve virologic suppression by their third trimester [41,42], the 
proportion of HIV-infected women undergoing cesarean delivery in the United States may 
decline. Indeed, in France the rate of elective cesarean delivery decreased since 2000 [31]; 
this has also been reported elsewhere in Europe [26]: The proportion of cesarean delivery in 
the French perinatal cohort was 52.9% in 2005 through 2010, which was twice the general 
French cesarean delivery rate [38]. In the same cohort, the proportion of elective cesarean 
trended from 56% in 2000 to 41% in 2004, whereas that for emergency cesarean section was 
stable at 29% [23]. In the European Collaborative study, the elective cesarean delivery rate 
for HIV-infected women declined from 67% in 1999–2001 to 51% by 2005–2007, whereas 
the emergency cesarean rate ranged from 15 to 17% in the HAART era [24].
Another obstetrical practice trend during this time period in the United tates which may 
account for some of the increases in elective cesarean deliveries observed (in both HIV-
infected and HIV-uninfected women) is the decrease in the rate of vaginal births after 
cesarean [43]. Our sensitivity analysis, however, did not demonstrate marked differences in 
the distributions of primary vs. repeat elective cesareans over time, or differences in 
complication rates per elective cesarean type.
This study has some limitations. NIS contains administrative data and lacks information on 
CD4+ cell count or receipt of ART; we based assumptions on the general utilization patterns 
of HAART among pregnant women in the United States over time. Some women may have 
not been tested for HIV or may have been unaware of their HIV status and thus 
misclassified as HIV-uninfected. Additionally, administrative data are affected by coding 
practices and may be subject to errors or omissions. We are unable to separate the elective 
cesarean deliveries that were performed for HIV prevention (i.e. scheduled cesarean 
deliveries) from those performed in HIV-infected women for another indication. This 
analysis may be limited in that estimates for surgical trauma and in-hospital death were 
based on few events in the HIV-infected women which may lead to unstable estimates. 
Finally, general changes in medical practices and in coding patterns may affect the study of 
trends over time; the study of HIV-uninfected women as the comparison group provides a 
measure of general trends in such practices, even though the contribution of particular 
factors is impossible to discern.
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In conclusion, despite declining over time, rates of infectious complications, surgical trauma 
and in-hospital deaths associated with cesarean delivery remain higher for HIV-infected, 
compared with HIV-uninfected women in the United States. Additionally, the overall 
proportion of cesarean deliveries among HIV-infected women’s deliveries has not decreased 
in the United States. The persistently elevated risk of cesarean delivery complications needs 
to be further evaluated among large cohorts of women at different stages of HIV disease and 
degrees of virologic suppression. Such risks need to be carefully weighed against any 
additional benefit in reduction in MTCT of HIV infection for women who are already on 
HAART regimens with good virologic suppression, in order to optimize the health of the 
mother–infant dyad.
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Table 3
Multivariable logistic and linear regression analysis for cesarean delivery-related complications, extended 
hospital stays, and deaths, and mean charges among HIV-infected and HIV-uninfected women, 1995/1996, 
2000/2001, 2005/2006 and 2010/2011.
aOR (95% CI)a
1995/1996 (REF) 2000/2001 2005/2006 2010/2011
All cesarean deliveries
  HIV-infected
    Any complication 1.0 0.84 (0.54–1.30) 0.57 (0.37–0.88) 0.53 (0.33–0.88)
    Infection 1.0 0.90 (0.60–1.33) 0.59 (0.40–0.86) 0.42 (0.27–0.66)
    Hemorrhage 1.0 0.67 (0.27–1.64) 0.47 (0.18–1.22) 0.76 (0.31–1.86)
    Surgical trauma 1.0 1.85 (0.43–8.00) 1.87 (0.44–8.01) 2.18 (.53–9.06)
    Hospital stay >7 days 1.0 0.41 (0.25–0.69) 0.42 (0.26–0.66) 0.56 (0.35–0.91)
    Deaths 1.0 – 0.08 (0.01–1.11) 0.37 (0.05–2.60)
    Adjusted mean charges (95% CI)b $15 793 (13 156–18 
431)
$14 154 (12 872–15 
435)
$16 882 (15 538–18 
226)
$24 104 (21 281–26 
926)
  HIV-uninfected
    Any complication 1.0 0.74 (0.68–0.81) 0.44 (0.40–0.48) 0.44 (0.39–0.50)
    Infection 1.0 0.81 (0.74–0.88) 0.44 (0.41–0.48) 0.32 (0.29–0.35)
    Hemorrhage 1.0 0.65 (0.54–.77) 0.51 (0.42–.62) 0.78 (0.62–0.99)
    Surgical trauma 1.0 0.56 (0.50–0.65) 0.44 (0.39–0.50) 0.36 (0.31–0.40)
    Hospital stay >7 days 1.0 0.83 (0.75–0.91) 0.70 (0.64–0.77) 0.61 (0.55–0.67)
    Deaths 1.0 0.81 (0.58–1.15) 0.52 (0.37–.72) 0.47 (0.34–0.66)
    Adjusted mean charges (95% CI)b $10 425 (10 172–10 
678)
$12 460 (11 975–12 
944)
$15 164 (14 654–15 
675)
$19 189 (18 411–19 
967)
  Elective cesarean deliveries
   HIV-infected
    Any complication 1.0 0.57 (0.36–0.91) 0.39 (0.24–0.63) 0.39 (0.23–0.65)
    Infection 1.0 0.59 (0.39–0.91) 0.41 (0.26–0.63) 0.30 (0.18–0.49)
    Hemorrhage 1.0 0.55 (0.20–1.55) 0.39 (0.13–1.21) 0.65 (0.23–1.84)
    Surgical trauma 1.0 4.14 (0.48–35.9) 3.20 (0.35–29.1) 4.73 (0.56–39.9)
    Hospital stay >7 days 1.0 0.32 (0.17–0.61) 0.35 (0.20–0.64) 0.49 (0.27–0.89)
    Deaths 1.0 – 0.05 (0.004–66) 0.23 (0.04–1.50)
    Adjusted mean charges (95% CI)b $17 391 (12848–21 
934)
$13 840 (12478–15 
203)
$16 686 (15 243–18 
128)
$23 932 (21 122–26 
741)
  HIV-uninfected
    Any complication 1.0 0.78 (0.71–0.84) 0.42 (0.39–0.46) 0.44 (0.39–0.49)
    Infection 1.0 0.85 (0.78–0.93) 0.42 (0.38–0.45) 0.30 (0.28–0.33)
    Hemorrhage 1.0 0.64 (0.54–0.76) 0.50 (0.41–0.30) 0.77 (0.62–0.97)
    Surgical trauma 1.0 0.56 (0.49–0.64) 0.44 (0.38–0.51) 0.35 (0.31–0.40)
    Hospital stay >7 days 1.0 0.84 (0.75–0.93) 0.68 (0.62–0.78) 0.59 (0.53–0.65)
    Deaths 1.0 0.79 (0.53–1.18) 0.50 (0.34–0.73) 0.43 (0.29–0.64)
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aOR (95% CI)a
1995/1996 (REF) 2000/2001 2005/2006 2010/2011
    Adjusted mean charges (95% CI)b $10 072 (9803–10 342) $12 091 (11643–12 
538)
$14 778 (14260–15 
295)
$18 571 (17 807–19 
336)
Results also shown for elective cesarean deliveries. aOR, adjusted odds ratio; CI, confidence interval; REF, referent group.
a
Adjusted for age group, primary expected payer, hospital teaching status/location, hospital region, alcohol/substance abuse, anemia and diabetes.
b
Multiple linear regression adjusted for age group, primary expected payer, hospital teaching status/location, hospital region, alcohol/substance 
abuse, anemia and diabetes.
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